NETRI logo

Lyon, France

Human neuronal models for drug development.

NETRI combines microfluidic cell culture, electrophysiology and data analysis to study how human neurons respond to drugs and other compounds.

The drugmaker problem

Pain, CIPN, and neurotox are still decided on the wrong animal.

Chemotherapy-induced neuropathy, pain, chemical neurotoxicity, and neurodegeneration are human nerve problems. The usual assays are a rodent, or a dish that cannot fire like a network.

Drugs, chemicals and cosmetics all need to be assessed for their effects on human nerves. Human neuronal models can provide more relevant answers than animal studies alone.

What they do

NETRI.

NETRI builds nerve-on-chip and neuron-as-a-sensor organ-on-chip platforms — NeuroFluidics and related systems — so human neural networks can live on a microfluidic chip and give a readable signal.

The work is pain, chemotherapy-induced peripheral neuropathy, neurotoxicity, neurodegeneration, and CNS. A human-relevant alternative to animal testing for pharma, chemical, and cosmetics companies.

Why you would use it

Where human neuronal models inform drug development.

  1. 01

    Chemotherapy-induced peripheral neuropathy and pain

    Assess whether chemotherapies and drug candidates affect the structure and electrical activity of human sensory neurons.

  2. 02

    Neurotoxicity

    Evaluate the effects of drugs, chemicals and cosmetic ingredients on the function of human neuronal networks, complementing in vivo safety studies.

  3. 03

    Neurodegeneration and CNS

    Measure functional readouts such as electrical activity and network connectivity in human neuronal models of central nervous system disease.

Who it is for

Pharma, chemical, and cosmetics teams — and the CROs and academics who support them — who need a human alternative to animal testing for nerve decisions.

Collaborations and programmes

NETRI is working with several pharmaceutical companies to evaluate its chemotherapy-induced neuropathic pain model. Public partners and programs are listed below.

On the board

RocketBio holds a board seat and supports business development.

netri.com

All investments

Vascularized 3D-bioprinted tissue

Considering the next chapter for your business?

We welcome conversations with owners of established scientific tools and technology businesses who are considering a long-term partner.

Talk to us about a transition